Status of vaccine research and development for enterotoxigenic Escherichia coli.
about
Impact of rotavirus vaccine introduction and post-introduction etiology of diarrhea requiring hospital admission in Haydom, Tanzania, a rural African setting.Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatmentEvaluation of the Probiotic Strain Bifidobacterium longum subsp. Infantis CECT 7210 Capacities to Improve Health Status and Fight Digestive Pathogens in a Piglet Model.Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant.Antibodies Damage the Resilience of Fimbriae, Causing Them To Be Stiff and TangledBioactive Immune Components of Anti-Diarrheagenic Enterotoxigenic Escherichia coli Hyperimmune Bovine Colostrum Products.Providing Structure to Enterotoxigenic Escherichia coli Vaccine Development.Colonization Factors in Enterotoxigenic Escherichia coli Strains in Travelers to Mexico, Guatemala, and India Compared with Children in Houston, Texas.Structural Characterization and Physicochemical Stability Profile of a Double Mutant Heat Labile Toxin Protein Based Adjuvant.A Chimeric protein of CFA/I, CS6 subunits and LTB/STa toxoid protects immunized mice against enterotoxigenic Escherichia coli.A Role for Salivary Peptides in the Innate Defense Against Enterotoxigenic Escherichia coli.Enterotoxigenic Escherichia coli blood group A interactions intensify diarrheal severity.Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers.An LTB-entrapped protein in PLGA nanoparticles preserves against enterotoxin of enterotoxigenic Escherichia coli.A Novel mcr-1 Variant Carried by an IncI2-Type Plasmid Identified From a Multidrug Resistant Enterotoxigenic Escherichia coli.HldE Is Important for Virulence Phenotypes in EnterotoxigenicProliferation of enterotoxigenic strain TW11681 in stools of experimentally infected human volunteersMorbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis Against Enterotoxigenic Escherichia coli Infection
P2860
Q30252225-C7499A23-865A-4045-9454-86BA9232A9BDQ36045476-53983298-C57D-49F0-803D-020F4E3A0E3EQ37746776-FFB8C55A-F081-47BC-8ABB-97D795E8D93BQ38678186-FC7B8C1D-B21D-4C09-A013-961DCB1FFF80Q39235361-223F69E8-9D7B-467C-A542-786B2E4772E7Q40163181-68BF7596-1C09-460C-8516-460529056C1DQ40199733-92E4B6C0-A181-4428-9A70-C5E9B24C0DE5Q40375701-02BC0E22-A833-491B-B9DF-FA41C70BD87EQ47305690-F8D5CD98-A1A3-448C-AB5A-DAB8A0BF6B56Q47753043-A12BC21C-D82B-4312-8A4B-2D4220F1C47DQ50419859-BCE876A9-A3A8-468D-B704-1716F8653F32Q54201990-806431DA-8E12-42EA-9038-70AE15D6F739Q55322314-D4394DE2-0F2B-4DBC-934E-24F0FFEF94FCQ55386075-9DABB294-26D6-45F8-B58E-83F9447C4C97Q55400128-96318FE6-614A-4F65-998A-1A3779D4CCD8Q57170400-17B0CF87-14AC-412B-AEF5-C2646873991AQ57814275-A1489AB6-1099-4321-87CE-D239C56CB276Q57927103-B5D4DD78-BC5B-423E-AD1B-65DF98897681Q57952623-FA43C9F0-4826-43DB-BFD3-BDC716A31921
P2860
Status of vaccine research and development for enterotoxigenic Escherichia coli.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Status of vaccine research and development for enterotoxigenic Escherichia coli.
@ast
Status of vaccine research and development for enterotoxigenic Escherichia coli.
@en
Status of vaccine research and development for enterotoxigenic Escherichia coli.
@nl
type
label
Status of vaccine research and development for enterotoxigenic Escherichia coli.
@ast
Status of vaccine research and development for enterotoxigenic Escherichia coli.
@en
Status of vaccine research and development for enterotoxigenic Escherichia coli.
@nl
prefLabel
Status of vaccine research and development for enterotoxigenic Escherichia coli.
@ast
Status of vaccine research and development for enterotoxigenic Escherichia coli.
@en
Status of vaccine research and development for enterotoxigenic Escherichia coli.
@nl
P2093
P1433
P1476
Status of vaccine research and development for enterotoxigenic Escherichia coli.
@en
P2093
A Louis Bourgeois
Richard I Walker
Thomas F Wierzba
P304
P356
10.1016/J.VACCINE.2016.02.076
P407
P577
2016-03-14T00:00:00Z